¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nerve tissue protein s 100"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • pudendal nerve
    À½ºÎ½Å°æ
  • parasympathetic nerve
    ºÎ±³°¨½Å°æ
  • palatine nerve
    ÀÔõÀå½Å°æ, ±¸°³½Å°æ
  • pectoral nerve
    °¡½¿±Ù½Å°æ, Èä±Ù½Å°æ
  • pelvic nerve
    °ñ¹Ý½Å°æ
  • pelvic splanchnic nerve
    °ñ¹Ý³»Àå½Å°æ
  • periarterial nerve plexus
    µ¿¸ÆÁÖÀ§½Å°æ¾ó±â
  • peripheral nerve
    ¸»ÃʽŰæ
  • peroneal nerve
    Á¾¾Æ¸®½Å°æ, ºñ°ñ½Å°æ
  • palmar digital nerve
    ¹Ù´ÚÂʼհ¡¶ô½Å°æ, ¼öÀåÃøÁö½Å°æ
  • palmar nerve
    ¼Õ¹Ù´Ú½Å°æ, ¼öÀå½Å°æ
  • petrosal nerve
    ¹ÙÀ§½Å°æ, Ãßü½Å°æ
  • pharyngeal nerve
    ÀενŰæ
  • radial nerve
    ³ë½Å°æ, ¿ä°ñ½Å°æ
  • recurrent laryngeal nerve
    µÇµ¹ÀÌÈĵνŰæ, ¹ÝȸÈĵνŰæ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • nasociliary nerve
    ÄÚ¼¶¸ðü½Å°æ
  • nasopalatine nerve
    ÄÚÀÔõÀå½Å°æ
  • nerve papilla
    ½Å°æÀ¯µÎ
  • nerve plexus
    ½Å°æ¾ó±â
  • nerve root
    ½Å°æ»Ñ¸®
  • nerve stimulator
    ½Å°æÀڱرâ
  • nerve terminal
    ½Å°æÁ¾¸»
  • nerve trunk
    ½Å°æÁÙ±â
  • nerve action potential
    ½Å°æÈ°µ¿Àü¾Ð
  • nerve cell process
    ½Å°æ¼¼Æ÷µ¹±â
  • nerve conduction velocity
    ½Å°æÀüµµ¼Óµµ
  • nerve ending organ
    ½Å°æ³¡±â°ü
  • nerve excitability test
    ½Å°æÀڱذ˻ç
  • nerve pedicle transfer
    ½Å°æÁÙ±âÀ̽Ä
  • obturator nerve
    Æó¼â½Å°æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • recurrent nerve injury
    ȸ±Í½Å°æ¼Õ»ó(üÞÏýãêÌèáßß¿).
  • recurrent nerve injury
    ȸ±Í½Å°æ¼Õ»ó(üÞÏýãêÌèáßß¿)
  • recurrent nerve paralysis
    ȸ±Í½Å°æ¸¶ºñ(üÞÏýãêÌè Ýö).
  • recurrent nerve paralysis
    ȸ±Í½Å°æ¸¶ºñ(üÞÏýãêÌèØ«Ýö)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • lymphoma,mucosa-associated lymphoid tissue
    Á¡¸·°ü·Ã ¸²ÇÁÁ¶Á÷(ïÄØ¯Î¼Ö¤ ¡­ðÚòÄ)
  • lymphoreticular tissue
    ¸²ÇÁ¼¼¸ÁÁ¶Á÷.
  • maternal tissue
    ¸ðüÁ¶Á÷(Ù½ô÷ðÚòÄ).
  • medium, tissue culture
    Á¶Á÷¹è¾ç¹èÁö
  • mesenchymal tissue
    Áß°£¿±Á¶Á÷, °£¿±Á¶Á÷(¡­ðÚòÄ).
  • mesenchymal tissue
    Áß°£¿±Á¶Á÷, °£¿±Á¶Á÷(¡­ðÚòÄ)
  • mesodermal tissue
    Á߹迱¼º Á¶Á÷(¡­ðÚòÄ).
  • mesodermal tissue
    Á߹迱¼º Á¶Á÷(¡­ðÚòÄ)
  • metanephric tissue cap
    ÈĽÅÀåÁ¶Á÷µ¤°³, ÈÄ ½ÅÁ¶Á÷¸ð(¡­ðÚòÄÙ¶).
  • mixed connective tissue disease
    È¥ÇÕ °áÇÕÁ¶Á÷º´
  • mixed connective tissue disease
    È¥ÇÕ¼º °áüÁ¶Á÷ Áúȯ(¡­ Ì¿ô÷ðÚòÄ òðü´)
  • mixed connective tissue disease
    È¥ÇÕ°áüÁ¶Á÷Áúȯ
  • mixed connective tissue disease(MCTD)
  • modified connective tissue
    º¯Çü°áÇÕÁ¶Á÷(ܨû¡Ì¿ùêðÚòÄ).
  • mucosa-associated lymphoid tissue
    Á¡¸·¿¬°ü¸²ÇÁÁ¶Á÷(¡­æáμ¡­ðÚòÄ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • Phrenic nerve
    °¡·Î¸·½Å°æ
    [¿¾ ¿ë¾î] Ⱦ°Ý½Å°æ
  • Nerve to piriformis
    ±ÃµÕ±¸¸Û±Ù½Å°æ
    [¿¾ ¿ë¾î] ÀÌ»ó±Ù½Å°æ
  • Efferent nerve fiber
    ³¯½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ¼öÃâ½Å°æ¼¶À¯
  • Oculomotor nerve (III)
    ´«µ¹¸²½Å°æ
    [¿¾ ¿ë¾î] µ¿¾È½Å°æ
  • Posterior interosseous nerve
    µÚ»À»çÀ̽Űæ
    [¿¾ ¿ë¾î] Èİñ°£½Å°æ
  • Optic nerve
    ½Ã°¢½Å°æ
    [¿¾ ¿ë¾î] ½Ã½Å°æ
  • Optic nerve (II)
    ½Ã°¢½Å°æ
    [¿¾ ¿ë¾î] ½Ã½Å°æ
  • Nerve fiber
    ½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ½Å°æ¼¶À¯
  • Nerve endings
    ½Å°æÁ¾¸»
    [¿¾ ¿ë¾î] ½Å°æÁ¾¸»
  • Perivenous nerve plexus
    Á¤¸ÆÁÖÀ§½Å°æ¾ó±â
    [¿¾ ¿ë¾î] Á¤¸ÆÁÖÀ§½Å°æÃÑ
  • Interosseous nerve of leg
    Á¾¾Æ¸®»À»çÀ̽Űæ
    [¿¾ ¿ë¾î] ÇÏÅð°ñ°£½Å°æ
  • Mixed nerve
    È¥ÇսŰæ
    [¿¾ ¿ë¾î] È¥ÇսŰæ
  • Sensory nerve
    °¨°¢½Å°æ
    [¿¾ ¿ë¾î] Áö°¢½Å°æ
  • Nerve cell [Neuron]
    ½Å°æ¼¼Æ÷ [½Å°æ´ÜÀ§]
    [¿¾ ¿ë¾î] ½Å°æ¼¼Æ÷
  • Nerve cell body
    ½Å°æ¼¼Æ÷ü
    [¿¾ ¿ë¾î] ½Å°æ¼¼Æ÷ü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
tPA tissue Plasminogen Activator
AT abdominal thrusts; achievement test; Achilles tendon; Achard-Thiers [syndrome]; adaptive thermogenes...
ATE acute toxic encephalopathy; adipose tissue extract; autologous tumor extract
BALT broncho-alveolar lavage fluid; bronchus-associated lymphoid tissue
BAT basic aid training; best available technology; blunt abdominal trauma; brown adipose tissue
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
%FTM fat tissue mass
NTCP's normal tissue complication probabilities
PET paraffin-embedded tissue
PTF primary tissue failure
STT soft tissue tumors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • parasympathetic nerve cell
    ºÎ±³°¨ ½Å°æ ¼¼Æ÷
  • paravertebral thoracic somatic nerve block
    ÈäÃß ÁÖÀ§ ü¼º ½Å°æ Â÷´Ü, ôÃß ÁÖÀ§ ÈäºÎ ü¼º ½Å°æ Â÷´Ü
  • periarterial nerve plexus
    µ¿¸Æ ÁÖÀ§ ½Å°æ ¾ó±â
  • perineal nerve
    »ô½Å°æ
  • peripheral nerve
    ¸»ÃÊ ½Å°æ
  • peripheral nerve stimulator
    ¸»ÃÊ ½Å°æ ÀÚ±Ø ÀåÄ¡
  • peripheral sensory nerve
    ¸»ÃÊ °¨°¢ ½Å°æ
  • perivascular nerve fiber
    Ç÷°ü ÁÖÀ§ ½Å°æ ¼¶À¯
  • peroneal nerve
    ºñ°ñ ½Å°æ
  • pharyngeal nerve plexus
    ÀεΠ½Å°æÃÑ
  • posterior auricular nerve
    µÚ ±Ó¹ÙÄû ½Å°æ, ÈÄÀ̰³ ½Å°æ
  • posterior deep temporal nerve
    ÈÄ½ÉºÎ ÃøµÎ ½Å°æ
  • posterior nerve root
    ÈÄ ½Å°æ±Ù
  • posterior superior alveolar nerve block
    ÈÄ»ó Ä¡Á¶ ½Å°æ ¸¶Ãë
  • posterior, middle superior alveolar nerve plexus
    ÈÄÁß»óÄ¡Á¶ ½Å°æÃÑ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
periplasmic protein disulfide oxidoreductase <enzyme> Isolated from haemophilus influenzae; may be required for assembly or folding of one or more disulfide-containing cell envelope proteins; ccmg isolated from paracoccus denitrificans
Registry number: EC 1.8.4.-
Synonym: por disulfide oxidoreductase, por gene product, periplasmic oxidoreductase, ccmg gene product
(26 Jun 1999)
ribose binding protein <protein> Periplasmic binding proteins of bacteria that interact either with the ribose transport system or with the methyl accepting chemotaxis protein MCP III (trg).
(18 Nov 1997)
ribosomal protein <protein> Proteins present within the ribosomal subunits. In prokaryotes there are 31 proteins in the large subunit and 21 in the small subunit. Eukaryotic subunits have 50 (large subunit) and 33 (small subunit) proteins.
(18 Nov 1997)
ribosomal protein s6 kinase <enzyme> A protein serine/threonine kinase which is involved in cell transformation by polyoma virus and is connected to the expression of igf2. The immunosuppressant rapamycin inhibits the activation of the kinase, leading to reduced translation of certain mRNAs and a decrease in protein synthesis.
Registry number: EC 2.7.10.-
(12 Dec 1998)
ribosomal protein S6 kinase kinase <enzyme> Isolated from unfertilised xenopus eggs; a 41 kD enzyme that is associated, in vivo, with phosphorylation on threonine and tyrosine residues and, in vitro, with phosphorylation on serine as well
Registry number: EC 2.7.1.-
Synonym: rsk kinase
(26 Jun 1999)
chk1 protein kinase <enzyme> A yeast protein kinase homolog, involved in cell-cycle arrest when DNA damage has occurred or when unligated DNA is present; named chk1 for checkpoint kinase; genbank af016582 (human), af016583 (murine)
Registry number: EC 2.7.1.-
Synonym: chk1 kinase, chk1 gene product, rad27 protein, rad27 gene product, hchk1 (human), mchk1 (murine), mammalian chk1
(26 Jun 1999)
green fluorescent protein <protein> A protein found in jellyfish which fluoresces, or glows green visible light when excited by UV light with a wavelength of 395 nanometres.
It can function as a biological marker when attached to other proteins. The structure of the protein is cylindrical with the glowing component, an amino acid complex called a fluorophore, in the middle of it.
(09 Oct 1997)
groel protein A chaperonin 60 heat-shock protein isolated from escherichia coli.
(12 Dec 1998)
groes protein A chaperonin 10 heat-shock protein isolated from escherichia coli.
(12 Dec 1998)
GTPase activating protein <molecular biology> Originally purified as a 125 kD protein from bovine brain (1044 amino acids), stimulates the GTPase activity of ras p21 and thereby switches it to the inactive state.
GAP may itself be regulated by phospholipids and by phosphorylation on a tyrosine residue by growth factor receptors (PDGF R, EGF R). The neurofibromatosis type 1 gene NF1) codes for a protein homologous to GAP. GAP has both SH2 and SH3 domains. Another example is sar 1 (from yeast).
(18 Nov 1997)
GTP-binding protein <molecular biology, protein> There are two main classes of G-proteins, the heterotrimeric G proteins that associate with receptors of the seven transmembrane domain superfamily and are involved in signal transduction and the small cytoplasmic G-proteins.
Regulatory proteins found in all cells. They are versatile molecular switches, involved in the control of a wide range of biological processes - protein synthesis, signal transduction pathways, growth and differentiation. They all act through a common molecular mechanism based on their ability to bind the guanine nucleotides GTP and GDP selectively and with high affinity.
Stimulatory G-proteins are permanently activated by cholera toxin, inhibitory ones by pertussis toxin. Transducin was one of the first of the heterotrimeric G-proteins to be identified.
The small G-proteins are a diverse group of monomeric GTPases that include ras, rab, rac and rho and that play an important part in regulating many intracellular processes including cytoskeletal organisation and secretion. Their GTPase activity is regulated by activators (GAPs) and inhibitors (GIPs) that determine the duration of the active state.
(12 Jul 2000)
RLK5-associated protein phosphatase <enzyme> Associated with serine-threonine receptor-like kinase, rlk5; from arabidopsis thaliana; composed of 3 domains, an amino-terminal signal anchor, a kinase interaction domain and a type 2c protein phosphatase catalytic domain; mw 65 kD; genbank u09505
Registry number: EC 3.1.3.-
Synonym: kapp, kinase-associated protein phosphatase
(26 Jun 1999)
guanosine triphosphate binding protein <protein> A type of protein embedded in the cytoplasmic membrane of the cell which transmits signals from outside the cell (such as from hormones binding to receptors on the outside of the cell) to the inside of the cell, where it causes some sort of biochemical reaction within the cell to the signal (such as the altering of metabolic pathways or gene expression). The process by which the protein does this is unclear but involves exchanging a molecule of GDP for a molecule of GTP.
(09 Oct 1997)
methyl accepting chemotaxis protein Methyl accepting chemotaxis proteins. Proteins of the inner cytoplasmic face of the bacterial plasma membane with which the receptors of the outer face interact. Four different MCPs are known in E. Coli, each with a separate set of receptors. Can be methylated at various sites, methylation is part of the adaptation to the signal. Although important intermediate signal integration sites, they are not directly connected to the motor.
(18 Nov 1997)
PfKIN protein kinase <enzyme> Snf1 type protein kinase from plasmodium flaciparum; genbank z22868
Registry number: EC 2.7.10.-
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
ÅëÇÕ°Ë»ö ¿Ï·á